2014 | Medical Innovation Summit

Now, it's Personal

Cancer Treatment and Personalized Medicine October 27-29, 2014 Cleveland, Ohio

 
  • Download Our FREE Mobile App

    Stay connected. Download today!

    appleStore.pnggooglePlay.png
  • 2014 Summit Preview

    Join more than 1,500 senior executives, investors, entrepreneurs and clinicians who will gather in Cleveland to discuss investable innovations that can lead to the detection and treatment of cancer. The 2014 Summit will include:
     

    • Detailed insights into the latest breakthroughs of personalized medicine
    • Discussions with world leaders responsible for the change in healthcare technology.
    • Top 10 Medical Innovations for 2015
       

2013 Speakers

| View All Speakers

Lars Sørensen

CEO, Novo Nordisk

Lars Sørensen | CEO, Novo Nordisk ,

Gregory Sorensen, MD, is the President and Chief Executive Officer of Siemens Healthcare in North America, charged with leading the U.S. organization and providing additional oversight for Canada and Latin America.

As a trendsetter in medical imaging, therapy systems, laboratory diagnostics, and healthcare information technology, Siemens Healthcare offers optimized clinical solutions across the entire care continuum – from prevention and early detection to diagnosis, treatment and follow-up. By offering novel tools for improved diagnosis, as well as optimizing clinical workflows for the most common conditions, Siemens helps make healthcare faster, better and more cost-effective. As head of the business in the largest global market, Sorensen brings to his leadership position a deep understanding of technology, the biological basis of disease, the importance of measurable outcomes, and the environment of clinical practice. Sorensen was appointed to his current role in June 2011.

Previously, Sorensen served as Professor of Radiology and Health Sciences & Technology at Harvard Medical School; faculty member of the Harvard-MIT Division of Health Sciences and Technology; and Co-Director of the A.A. Martinos Center for Biomedical Imaging at Massachusetts General Hospital, as well as a visiting professor of neuroradiology at Oxford University.

Leading up to his appointment with Siemens, Sorensen was a practicing neuroradiologist and active researcher with significant experience in clinical care, clinical trials, and translational research. His research and techniques are utilized by scores of centers throughout the world in phase II and III trials in cancer, stroke, and other illnesses.

Sorensen holds a BS in biology from California Institute of Technology, a MS in computer science from Brigham Young University, and a MD from Harvard Medical School. He is married with three children.

Liz Claman

Anchor, FOX Business Network

Liz Claman | Anchor, FOX Business Network ,

Liz Claman joined FOX Business Network (FBN) as an anchor in October 2007. She anchors Countdown to the Closing Bell which is presented from 3-4pm EST as well as co-anchors After the Bell from 4-5pm EST.

Her October debut on FBN included an exclusive interview with Berkshire Hathaway CEO and legendary investor Warren Buffett. Throughout her tenure at FBN, Claman has conducted exclusive interviews with former Intel CEO Paul Otellini, Ford CEO Alan Mulally, Google Executive Chairman Eric Schmidt, JPMorgan Chase Chairman and CEO Jamie Dimon, former United States Treasury Secretary Timothy Geithner, as well as joint interviews with Buffett, Berkshire Hathaway Vice Chairman Charlie Munger and Microsoft Co-Founder Bill Gates at Berkshire Hathaway’s Annual Shareholder meetings in Omaha, Nebraska.

Prior to joining FBN, Claman served as an anchor at CNBC, most recently anchoring Morning Call and Cover to Cover. During her time at CNBC, Claman has interviewed major financial newsmakers, including Warren Buffett, Commerce Secretary Carlos Gutierrez, and former Treasury Secretary John Snow. She has also anchored Wake Up Call, Market Watch, and Today’s Business.

Before CNBC, Claman served as an anchor and reporter for Boston’s WHDH-TV (NBC). She was also a contributing correspondent for NBC’s syndicated daytime program RealLife. Prior to that, she anchored a two-hour daily talk show, The Morning Exchange for WEWS-TV (ABC) in Cleveland. She received an Emmy for her work on The Morning Exchange.

A graduate of the University of California, Berkeley, Claman began her on-air career at WSYX-TV (ABC) in Columbus, Ohio as a reporter and later a weekend anchor. Earlier, she was a news associate for KCBS-TV (CBS) in Los Angeles where she was the youngest person in the station’s history to win a local Emmy Award for Best Spot Producer.

José E. Almeida

CEO, Covidien

José E. Almeida | CEO, Covidien ,

José E. Almeida has been the President, Chief Executive Officer and a Director of Covidien since July 2011. Mr. Almeida became Chairman of the Board of Directors in March 2012. Prior to being elected President and Chief Executive Officer, Mr. Almeida was President of the Medical Devices segment of Covidien. In this position, Mr. Almeida oversaw the Surgical Devices, Energy-based Devices, Respiratory & Monitoring Solutions and Vascular Therapies Global Business Units, as well as the Japan, Asia, Canada and Latin America regions. These businesses account for approximately two-thirds of the Company’s total annual revenues and about three-quarters of its operating profit.

Mr. Almeida joined Covidien in 1995 as Director of Manufacturing and Corporate Engineering, and then held several positions of increasing responsibility, including Vice President of European Manufacturing and Vice President of Global Manufacturing. Mr. Almeida left in 2003 for Greatbatch Technologies, Inc., a leading manufacturer of power sources and components for implantable medical devices, before returning to Covidien in 2004 as President of the International Business Unit.

Before joining Covidien, Mr. Almeida was a Director of Manufacturing in American Home Products’ Acufex Microsurgical division, an Engineering Manager of Johnson & Johnson’s Professional Products division and a Management Consultant at Andersen Consulting (Accenture). Mr. Almeida received a Bachelor’s degree from Escola de Engenharia Maua in São Paulo, Brazil. He currently serves on the Board of Directors of Advanced Medical Technology Association (AdvaMed).

Why Attend?

The Medical Innovation Summit provides an unrivaled perspective on the newest medical innovations and the financial drivers behind those innovations. The conference is recognized for providing singular insights, networking opportunities and actionable take away for all participants. The content is designed for:

  • Senior executives in the healthcare industry
  • Clinical, medical affairs, regulatory and business development executives
  • Venture capitalists and angel investor groups
  • Investment bankers
  • Buy-side and sell-side researchers
  • Consulting, legal and other service providers

Agenda Highlights

Monday | October 27th
  • New Ventures Healthcare Challenge
  • The State of Healthcare Innovation
  • Dinner and Keynote Address
Tuesday | October 28th
  • Live Surgery
  • The Business of Cancer Diagnostics
  • Imaging and Cancer Detection
  • Networking Recepton
Wednesday | October 29th
  • Therapeutics and Pharmaceuticals
  • Radiation
  • Revealing of the Top 10 Medical Innovations for 2015

2013 Sponsors

View All Past Sponsors

PREMIER
SPONSORS
PLATINUM
SPONSORS